Atai Life Sciences to Invest $5 Million in Bitcoin as a Hedge Against Inflation Amid Regulatory Delays
Biopharmaceutical firm Atai Life Sciences has joined the growing list of publicly traded companies investing in Bitcoin. In a March 20 Substack post, Christian Angermayer, Atai’s founder and chair, announced that the company plans to acquire $5 million worth of Bitcoin, citing its potential as a financial safeguard for biotech ...
